Last viewed: CMPI

Prices are updated after-hours

CMPI Nasdaq

Checkmate Pharmaceuticals, Inc.

CMPI | $10.5 0.0%

|

Health Technology

(0.0% 1d) (0.2% 1m) (0.0% 1y) (0.2% 2d) (0.1% 3d) (0.0% 7d) (-49.8% volume)
Earnings Calendar: 2022-08-11
Market Cap:
http://www.checkmatepharma.com
Sec Filling | Patents | 22 employees

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. It specializes in the field of CpG oligonucleotides. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.

cancer

add to watch list Paper trade email alert is off

Press-releases

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
TSVT | $4.815 -4.46% 210K

|

| -3.95% | O: -1.16% H: 9.94% C: 2.34%
SNY | $45.99 0.13% 70K

|

Health Technology

| -3.28% | O: -0.93% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

|

Health Technology

| -6.18% | O: 1.4% H: 0.28% C: -2.68%
ALNY | $147.285 -0.28% 13K

|

Health Technology

| -15.56% | O: -1.23% H: 1.0% C: 0.17%
year financial results

Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published: 2023-02-03 (Crawled : 12:00) - globenewswire.com
SNYNF | $92.966 630

|

Health Technology

| -5.67% | O: -5.75% H: 0.0% C: 0.0%
SNY | $45.99 0.13% 70K

|

Health Technology

| -2.05% | O: -4.01% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 19.62% | O: 1.77% H: 3.33% C: 2.44%
CTMX | $1.925 -2.28% 110K

|

Health Technology

| -23.94% | O: 0.39% H: 4.23% C: 1.92%
ACET | $2.155 -2.05% 23K

|

Health Technology

| -76.16% | O: -1.63% H: 1.98% C: -3.52%
year financial results

Regeneron Reports Second Quarter 2022 Financial and Operating Results
Published: 2022-08-03 (Crawled : 11:00) - prnewswire.com
SNYNF | $92.966 630

|

Health Technology

| -7.76% | O: -2.6% H: 0.0% C: -0.76%
SNY | $45.99 0.13% 70K

|

Health Technology

| -5.44% | O: -0.17% H: 0.12% C: -1.29%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 56.28% | O: 4.36% H: 3.91% C: 1.46%
results

Regeneron Completes Purchase of Sanofi's Stake in Libtayo® (cemiplimab)
Published: 2022-07-01 (Crawled : 12:00) - prnewswire.com
SNY | $45.99 0.13% 70K

|

Health Technology

| -6.58% | O: 0.26% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 52.01% | O: -0.57% H: 1.57% C: 1.3%
libtayo

Kuros Biosciences: Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers a $5 Million Milestone Payment
Published: 2022-06-02 (Crawled : 06:00) - globenewswire.com
XOMA | $24.34 2.1K

|

Health Technology

| 29.54% | O: -8.73% H: 5.95% C: 4.37%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 34.19% | O: -2.18% H: 0.0% C: -3.71%
acquisition payment milestone

Regeneron Completes Acquisition of Checkmate Pharmaceuticals
Published: 2022-05-31 (Crawled : 13:20) - biospace.com/
SNYNF | $92.966 630

|

Health Technology

| -15.02% | O: -2.5% H: 0.54% C: 0.54%
SNY | $45.99 0.13% 70K

|

Health Technology

| -14.44% | O: -3.21% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 31.78% | O: 1.6% H: 0.0% C: -4.05%
acquisition

Regeneron Reports First Quarter 2022 Financial and Operating Results
Published: 2022-05-04 (Crawled : 11:00) - prnewswire.com
SNY | $45.99 0.13% 70K

|

Health Technology

| -12.25% | O: -3.68% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

|

Health Technology

| 38.15% | O: 1.63% H: 0.0% C: 0.0%
NTLA | $22.52 -1.75% 160K

|

Health Technology

| -55.54% | O: -0.5% H: 0.0% C: 0.0%
CMPI | $10.5 0.0%

|

Health Technology

| 1.06% | O: 0.0% H: 0.0% C: -0.19%
ACET | $2.155 -2.05% 23K

|

Health Technology

| -85.61% | O: 0.46% H: 0.0% C: 0.0%
results

Checkmate Pharmaceuticals Announces Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-29 (Crawled : 21:00) - globenewswire.com
CMPI | $10.5 0.0%

|

Health Technology

| 227.1% | O: -1.25% H: 2.52% C: 1.58%
results

Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
CMPI | $10.5 0.0%

|

Health Technology

| 228.13% | O: 6.56% H: 0.29% C: 0.0%
america als research cancer

Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors
Published: 2022-01-31 (Crawled : 22:00) - biospace.com/
CMPI | $10.5 0.0%

|

Health Technology

| 379.45% | O: 0.91% H: 10.41% C: 10.41%
als

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

48%

52%

Top 10 Gainers

TPET | $0.4801 107.75% 16M

|

JAGX | $0.23 93.6% 310M

|

Health Technology

WISA 4 | $3.17 81.14% 36M

|

Electronic Technology

PALI | $7.41 78.13% 14M

|

SPCB | $0.4278 55.0% 17M

|

Electronic Technology

BTTR | $7.61 49.22% 1.8M

|

PRSO | $1.79 40.95% 25M

|

DYNT | $0.5203 40.47% 17M

|

Health Technology

MCBC | $13.755 38.52% 620K

|

SNGX | $0.5155 33.52% 3.9M

|

Health Technology

Last 48 Hours Insiders Buying

RMCF | $3.6492 3.6K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar